Literature DB >> 16952043

Helicobacter pylori-negative / API2-MALT1 translocation-negative low-grade MALT lymphoma.

Koji Nozaki1, Sachiyo Nomura, Nobuyuki Shimizu, Naoki Hiki, Nao Yoshizawa, Susumu Aikou, Keisuke Kubota, Hirokazu Yamaguchi, Hanzo Kurosaka, Aya Shinozaki, Ken-ichi Mafune, Masashi Fukayama, Michio Kaminishi.   

Abstract

A 71-year-old man with a Helicobacter pylori infection-negative and API2-MALT1 translocation-negative extranodal marginal-zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) type of the stomach has been followed conservatively for over 5 years. The lesion has shown no major morphological changes or malignant progression into a diffuse large-cell type during the time course. The absence of genetic translocation of API2-MALT1 was confirmed with fluorescence in situ hybridization (FISH). The prognosis of H. pylori-negative and API2-MALT1 translocation-negative low-grade MALT lymphoma is unknown, and a standard treatment for such lymphoma has yet to be defined. The case of MALT lymphoma negative for both of the above factors that we report has shown no obvious rapid progression or malignant change over the long-term course. Although curative operation and/or chemoradiotherapy should still be discussed as the treatment of choice, the treatment of this type of lymphoma must be carefully determined on a case-by-case basis, according to its biological status and prognosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16952043     DOI: 10.1007/s10120-006-0367-6

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  24 in total

1.  Clinicopathological features of gastric mucosa-associated lymphoid tissue lymphoma: a comparison with diffuse large B-cell lymphoma without a mucosa-associated lymphoid tissue lymphoma component.

Authors:  T Hiyama; K Haruma; Y Kitadai; H Masuda; M Miyamoto; M Ito; T Kamada; S Tanaka; N Uemura; M Yoshihara; K Sumii; F Shimamoto; K Chayama
Journal:  J Gastroenterol Hepatol       Date:  2001-07       Impact factor: 4.029

2.  API2-MALT1 chimeric transcripts involved in mucosa-associated lymphoid tissue type lymphoma predict heterogeneous products.

Authors:  M Motegi; M Yonezumi; H Suzuki; R Suzuki; Y Hosokawa; S Hosaka; Y Kodera; Y Morishima; S Nakamura; M Seto
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

3.  T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication.

Authors:  Hongxiang Liu; Hongtao Ye; Agnes Ruskone-Fourmestraux; Daphne De Jong; Stefano Pileri; Christian Thiede; Anne Lavergne; Henk Boot; Giancarlo Caletti; Thomas Wündisch; Thierry Molina; Babs G Taal; Sabattini Elena; Togliani Thomas; Pier Luigi Zinzani; Andreas Neubauer; Manfred Stolte; Rifat A Hamoudi; Ahmet Dogan; Peter G Isaacson; Ming-Qing Du
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

4.  T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10.

Authors:  H Liu; H Ye; A Dogan; R Ranaldi; R A Hamoudi; I Bearzi; P G Isaacson; M Q Du
Journal:  Blood       Date:  2001-08-15       Impact factor: 22.113

5.  MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.

Authors:  Hongtao Ye; Liping Gong; Hongxiang Liu; Rifat A Hamoudi; Sima Shirali; Liza Ho; Andreas Chott; Berthold Streubel; Reiner Siebert; Stefan Gesk; Jose I Martin-Subero; John A Radford; Sankar Banerjee; Andrew G Nicholson; Renzo Ranaldi; Ellen D Remstein; Zifen Gao; Jie Zheng; Peter G Isaacson; Ahmet Dogan; Ming-Qing Du
Journal:  J Pathol       Date:  2005-02       Impact factor: 7.996

Review 6.  Chromosomal translocation t(11;18)(q21;q21) in gastrointestinal mucosa associated lymphoid tissue lymphoma.

Authors:  S Nakamura; T Matsumoto; S Nakamura; Y Jo; K Fujisawa; H Suekane; T Yao; M Tsuneyoshi; M Iida
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

7.  Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32).

Authors:  Q Zhang; R Siebert; M Yan; B Hinzmann; X Cui; L Xue; K M Rakestraw; C W Naeve; G Beckmann; D D Weisenburger; W G Sanger; H Nowotny; M Vesely; E Callet-Bauchu; G Salles; V M Dixit; A Rosenthal; B Schlegelberger; S W Morris
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

8.  Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes.

Authors:  Keigo Machida; Kevin T-N Cheng; Vicky M-H Sung; Shigetaka Shimodaira; Karen L Lindsay; Alexandra M Levine; Ming-Yang Lai; Michael M C Lai
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-03       Impact factor: 11.205

Review 9.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

10.  Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group.

Authors:  E Bayerdörffer; A Neubauer; B Rudolph; C Thiede; N Lehn; S Eidt; M Stolte
Journal:  Lancet       Date:  1995-06-24       Impact factor: 79.321

View more
  1 in total

1.  First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  Sung-Hsin Kuo; Kun-Huei Yeh; Ming-Shiang Wu; Chung-Wu Lin; Ming-Feng Wei; Jyh-Ming Liou; Hsiu-Po Wang; Li-Tzong Chen; Ann-Lii Cheng
Journal:  Sci Rep       Date:  2017-10-30       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.